Literature DB >> 19270193

Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke.

Daniel J Conklin1, Petra Haberzettl, Russell A Prough, Aruni Bhatnagar.   

Abstract

Exposure to tobacco smoke impairs endothelium-dependent arterial dilation. Reactive constituents of cigarette smoke are metabolized and detoxified by glutathione-S-transferases (GSTs). Although polymorphisms in GST genes are associated with the risk of cancer in smokers, the role of these enzymes in regulating the cardiovascular effects of smoking has not been studied. The P isoform of GST (GSTP), which catalyzes the conjugation of electrophilic molecules in cigarette smoke such as acrolein, was expressed in high abundance in the mouse lung and aorta. Exposure to tobacco smoke for 3 days (5 h/day) decreased total plasma protein. These changes were exaggerated in GSTP(-/-) mice. Aortic rings isolated from tobacco smoke-exposed GSTP(-/-) mice showed greater attenuation of ACh-evoked relaxation than those from GSTP(+/+) mice. The lung, plasma, and aorta of mice exposed to tobacco smoke or acrolein (for 5 h) accumulated more acrolein-adducted proteins than those tissues of mice exposed to air, indicating that exposure to tobacco smoke results in the systemic delivery of acrolein. Relative to GSTP(+/+) mice, modification of some proteins by acrolein was increased in the aorta of GSTP(-/-) mice. Aortic rings prepared from GSTP(-/-) mice that inhaled acrolein (1 ppm, 5 h/day for 3 days) or those exposed to acrolein in an organ bath showed diminished ACh-induced arterial relaxation more strongly than GSTP(+/+) mice. Acrolein-induced endothelial dysfunction was prevented by pretreatment of the aorta with N-acetylcysteine. These results indicate that GSTP protects against the endothelial dysfunction induced by tobacco smoke exposure and that this protection may be related to the detoxification of acrolein or other related cigarette smoke constituents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270193      PMCID: PMC2685347          DOI: 10.1152/ajpheart.00867.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  47 in total

1.  Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer.

Authors:  L W Harries; M J Stubbins; D Forman; G C Howard; C R Wolf
Journal:  Carcinogenesis       Date:  1997-04       Impact factor: 4.944

2.  Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases.

Authors:  C J Henderson; A G Smith; J Ure; K Brown; E J Bacon; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 3.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.

Authors:  J D Hayes; D J Pulford
Journal:  Crit Rev Biochem Mol Biol       Date:  1995       Impact factor: 8.250

4.  Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase.

Authors:  S Srivastava; T M Harter; A Chandra; A Bhatnagar; S K Srivastava; J M Petrash
Journal:  Biochemistry       Date:  1998-09-15       Impact factor: 3.162

5.  Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution.

Authors:  M A Watson; R K Stewart; G B Smith; T E Massey; D A Bell
Journal:  Carcinogenesis       Date:  1998-02       Impact factor: 4.944

6.  Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  G Howard; L E Wagenknecht; G L Burke; A Diez-Roux; G W Evans; P McGovern; F J Nieto; G S Tell
Journal:  JAMA       Date:  1998-01-14       Impact factor: 56.272

7.  Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene.

Authors:  X Hu; X Ji; S K Srivastava; H Xia; S Awasthi; B Nanduri; Y C Awasthi; P Zimniak; S V Singh
Journal:  Arch Biochem Biophys       Date:  1997-09-01       Impact factor: 4.013

Review 8.  Human glutathione S-transferases.

Authors:  Y C Awasthi; R Sharma; S S Singhal
Journal:  Int J Biochem       Date:  1994-03

9.  Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases.

Authors:  K Berhane; M Widersten; A Engström; J W Kozarich; B Mannervik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

Review 10.  Fate and effects of acrolein.

Authors:  D P Ghilarducci; R S Tjeerdema
Journal:  Rev Environ Contam Toxicol       Date:  1995       Impact factor: 7.563

View more
  51 in total

1.  Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids.

Authors:  Karin Wetzelberger; Shahid P Baba; Mahesh Thirunavukkarasu; Ye-Shih Ho; Nilanjana Maulik; Oleg A Barski; Daniel J Conklin; Aruni Bhatnagar
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).

Authors:  Shahid P Baba; Jason Hellmann; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

3.  Crotonaldehyde-induced vascular relaxation and toxicity: Role of endothelium and transient receptor potential ankyrin-1 (TRPA1).

Authors:  L Jin; G Jagatheesan; J Lynch; L Guo; D J Conklin
Journal:  Toxicol Appl Pharmacol       Date:  2020-04-19       Impact factor: 4.219

4.  Acrolein-induced dyslipidemia and acute-phase response are independent of HMG-CoA reductase.

Authors:  Daniel J Conklin; Russell A Prough; Peter Juvan; Tadeja Rezen; Damjana Rozman; Petra Haberzettl; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Mol Nutr Food Res       Date:  2011-08-03       Impact factor: 5.914

5.  Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice.

Authors:  Sanjay Srivastava; Srinivas D Sithu; Elena Vladykovskaya; Petra Haberzettl; David J Hoetker; Maqsood A Siddiqui; Daniel J Conklin; Stanley E D'Souza; Aruni Bhatnagar
Journal:  Atherosclerosis       Date:  2011-03-02       Impact factor: 5.162

6.  The tobacco smoke component, acrolein, suppresses innate macrophage responses by direct alkylation of c-Jun N-terminal kinase.

Authors:  Milena Hristova; Page C Spiess; David I Kasahara; Matthew J Randall; Bin Deng; Albert van der Vliet
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

7.  Exposure to acrolein by inhalation causes platelet activation.

Authors:  Srinivas D Sithu; Sanjay Srivastava; Maqsood A Siddiqui; Elena Vladykovskaya; Daniel W Riggs; Daniel J Conklin; Petra Haberzettl; Timothy E O'Toole; Aruni Bhatnagar; Stanley E D'Souza
Journal:  Toxicol Appl Pharmacol       Date:  2010-08-03       Impact factor: 4.219

8.  Cigarette smoke causes lung vascular barrier dysfunction via oxidative stress-mediated inhibition of RhoA and focal adhesion kinase.

Authors:  Qing Lu; Pavlo Sakhatskyy; Katie Grinnell; Julie Newton; Melanie Ortiz; Yulian Wang; Juan Sanchez-Esteban; Elizabeth O Harrington; Sharon Rounds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-07       Impact factor: 5.464

9.  Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7a.

Authors:  Timothy E O'Toole; Wesley Abplanalp; Xiaohong Li; Nigel Cooper; Daniel J Conklin; Petra Haberzettl; Aruni Bhatnagar
Journal:  Toxicol Sci       Date:  2014-05-08       Impact factor: 4.849

10.  The glutaredoxin/S-glutathionylation axis regulates interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with S-glutathionylation of nuclear factor κB family proteins.

Authors:  James D Nolin; Jane E Tully; Sidra M Hoffman; Amy S Guala; Jos L van der Velden; Matthew E Poynter; Albert van der Vliet; Vikas Anathy; Yvonne M W Janssen-Heininger
Journal:  Free Radic Biol Med       Date:  2014-05-09       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.